Want to see IN:DRREDDY full AI Analyst Report?
Dr. Reddy's Laboratories Ltd. (DRREDDY) Financial Statements
Dr. Reddy's Laboratories Ltd. Financial Overview
Dr. Reddy's Laboratories Ltd.'s market cap is currently $1.13T. The company's EPS TTM is $33.60; its P/E ratio is 40.24; and it has a dividend yield of 0.59%. Dr. Reddy's Laboratories Ltd. is scheduled to report earnings on January 22, 2027, and the estimated EPS forecast is $11.90. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 335.93B | $ 325.54B | $ 279.16B | $ 245.88B | $ 214.39B |
| Gross Profit | $ 177.26B | $ 190.43B | $ 163.61B | $ 139.34B | $ 113.84B |
| Operating Income | $ 46.44B | $ 71.84B | $ 67.73B | $ 57.14B | $ 29.48B |
| EBITDA | $ 79.16B | $ 90.09B | $ 80.43B | $ 65.92B | $ 47.74B |
| Net Income | $ 42.85B | $ 56.54B | $ 55.68B | $ 45.07B | $ 23.57B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 87.81B | $ 57.91B | $ 81.47B | $ 61.80B | $ 44.37B |
| Total Assets | $ 579.35B | $ 492.99B | $ 387.52B | $ 322.85B | $ 296.65B |
| Total Debt | $ 89.54B | $ 46.77B | $ 20.02B | $ 13.47B | $ 33.84B |
| Net Debt | $ 74.18B | $ 32.11B | $ 12.91B | $ 7.69B | $ 18.99B |
| Total Liabilities | $ 198.89B | $ 155.82B | $ 106.97B | $ 89.99B | $ 106.13B |
| Stockholders' Equity | $ 377.06B | $ 333.39B | $ 280.55B | $ 230.99B | $ 190.53B |
| Cash Flow | |||||
| Free Cash Flow | $ 30.51B | $ 18.92B | $ 18.00B | $ 40.01B | $ 9.06B |
| Operating Cash Flow | $ 53.84B | $ 46.43B | $ 45.43B | $ 58.87B | $ 28.11B |
| Investing Cash Flow | $ -67.03B | $ -51.02B | $ -40.28B | $ -41.37B | $ -26.39B |
| Financing Cash Flow | $ 12.73B | $ 11.86B | $ -3.76B | $ -26.86B | $ -2.42B |
Currency in INR